Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Despite an Industry-Wide Decline, Some Pharmaceutical Companies Are Increasing Speaker Program Budgets
Pharmiweb
Saturday, December 7, 2013 - 1:22pm
tags:
drug marketing
Do Drugmaker Plans To Release Trial Data Go Far Enough?
Forbes
Saturday, December 7, 2013 - 1:17pm
tags:
3 Budding Drug Superstars in This Big Pharma's Future
Motley Fool
Saturday, December 7, 2013 - 1:12pm
tags:
Bristol-Myers Squibb
Johnson & Johnson Battles St. Jude for Cardiac Mapping Leadership
Motley Fool
Saturday, December 7, 2013 - 12:56pm
tags:
JNJ, St. Jude Medical, cardiac mapping
Increased Biotech Productivity and Innovation Reflected in FDA-Approved Drugs: One of the Top 10 Equity Analyst Interviews of 2013
Yahoo/Wall St Transcript
Saturday, December 7, 2013 - 12:54pm
tags:
High-Risk Pipeline Candidates and Limited Options Make Novartis an Iffy Buy Candidate
Motley Fool
Saturday, December 7, 2013 - 12:53pm
tags:
Novartis
Theravance, Glaxo COPD Drug Does Well In Asthma
investors.com
Saturday, December 7, 2013 - 12:52pm
tags:
Theravance
Arena Eyes Additional Opportunity With Belviq
Seeking Alpha
Saturday, December 7, 2013 - 12:50pm
tags:
Arena Pharmaceuticals, Belviq, smoking cessation, type 2 diabetes
HIV Returns in Two Men Thought Cured After Stem Cell Transplant
Bloomberg
Saturday, December 7, 2013 - 12:48pm
tags:
HIV, stem cells
Infinity Reports Preclinical Data at ASH Annual Meeting in Diffuse Large B-Cell Lymphoma and T-Cell Acute Lymphoblastic Leukemia Suggesting Broad Potential of IPI-145 in Blood Cancers
Yahoo/BusinessWire
Saturday, December 7, 2013 - 12:47pm
tags:
large B-cell lymphoma, lymphoma, leukemia, T-cell acute lymphoblastic leukemia, IPI-145, Infinity Pharmaceuticals
ZIOPHARM Reports Positive Interim Results in Patients With Advanced Melanoma From Ongoing Phase 1/2 Study of Ad-RTS-IL-12
Yahoo/Globe Newswire
Saturday, December 7, 2013 - 12:44pm
tags:
Ziopharm, melanoma, Ad-RTS-IL-12
Is Celldex Offering a Reason to Be Scared?
Motley Fool
Saturday, December 7, 2013 - 12:42pm
tags:
Celldex
Why Is Actelion Suppressing Phase III Data?
Forbes
Friday, December 6, 2013 - 5:49pm
tags:
Actelion, almorexant, insomnia
High-Risk Pipeline Candidates and Limited Options Make Novartis an Iffy Buy Candidate
Motley Fool
Friday, December 6, 2013 - 5:48pm
tags:
Novartis
FDA approves first drug option for rare disease that causes painful, curved erections in men
Yahoo/AP
Friday, December 6, 2013 - 5:44pm
tags:
Peyronie's Disease, FDA, Auxilium, Xiaflex
Belviq Sales During The Holiday Week
Seeking Alpha
Friday, December 6, 2013 - 5:42pm
tags:
Arena Pharmaceuticals, Belviq, Eisai
Gilead Wins FDA Approval for Blockbuster Hepatitis C Pill
Bloomberg
Friday, December 6, 2013 - 5:41pm
tags:
sofosbuvir, FDA, Gilead Science, hepatitis C, Sovaldi
AstraZeneca is first to win EU approval for an inhaled 4-in-1 flu vaccine
Fierce Pharma
Friday, December 6, 2013 - 11:57am
tags:
vaccines, Europe, Flu, flu vaccines, AstraZeneca, Fluenz Tetra
Actavis' former CEO is betting on biosimilars
Fierce Pharma
Friday, December 6, 2013 - 11:56am
tags:
Actavis, biosimilars, Alvogen
More Catalysts For MannKind
Seeking Alpha
Friday, December 6, 2013 - 11:12am
tags:
MannKind, Afrezza, diabetes, insulin

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.